VU0514009

VU0514009
Identifiers
	IUPAC name 2-{[5-(3-chloro-4-methylbenzenesulfonyl)-6-oxo-1,6-dihydropyrimidin-2-yl]sulfanyl}-N-(2-methoxy-5-methylphenyl)acetamide;
CAS Number	932973-77-8;
PubChem CID	16875894;
ChemSpider	20425435;
Chemical and physical data
Formula	C21H20ClN3O5S2
Molar mass	493.98 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CC1=CC(=C(C=C1)OC)NC(=O)CSC2=NC=C(C(=O)N2)S(=O)(=O)C3=CC(=C(C=C3)C)Cl;
	InChI InChI=1S/C21H20ClN3O5S2/c1-12-4-7-17(30-3)16(8-12)24-19(26)11-31-21-23-10-18(20(27)25-21)32(28,29)14-6-5-13(2)15(22)9-14/h4-10H,11H2,1-3H3,(H,24,26)(H,23,25,27); Key:UODSZPFBKYQNFN-UHFFFAOYSA-N;

VU0514009 is a synthetic drug derived through high-throughput screening which acts as a selective antagonist of the CMKLR1 receptor, though also shows some affinity for the closely related receptor GPR1. It was developed for research into the structure and function of these receptors, and several related compounds have been derived from the initial screening hit.^[1]

References

^ Schermeng T, Fürll A, Liessmann F, von Bredow L, Stichel J, Weaver CD, et al. (June 2025). "Similar Binding Mode of a 5-Sulfonylthiouracil Derivative Antagonist at Chemerin Receptors CMKLR1 and GPR1". Journal of Medicinal Chemistry. 68 (11): 11149–11173. doi:10.1021/acs.jmedchem.5c00135. PMC 12169613. PMID 40377914.

[Schermeng_2025-1] Schermeng T, Fürll A, Liessmann F, von Bredow L, Stichel J, Weaver CD, et al. (June 2025). "Similar Binding Mode of a 5-Sulfonylthiouracil Derivative Antagonist at Chemerin Receptors CMKLR1 and GPR1". Journal of Medicinal Chemistry. 68 (11): 11149–11173. doi:10.1021/acs.jmedchem.5c00135. PMC 12169613. PMID 40377914.

[1]